Employer Name
OphtiMed Rx
OphtiMed Rx
OphtiMedRx LTD is an ophthalmic drug development company (Preclinical stage)
OphtiMedRx LTD is an ophthalmic drug development company supported by Galil Ofek Ventures, Mor Research Applications, and RunYoung organization. The company is developing a novel innovative molecular pharmacotherapy for dry Age-related Macular Degeneration (AMD), a common eye disease leading to blindness with a multi-billion USD market opportunity.
Pharmaceuticals, BioTech
Pre-seed
https://www.galilofek.com/ophtimedrx/
1-10
Katsrin